MiR‐149‐3p can improve the osteogenic differentiation of human adipose‐derived stem cells via targeting AKT1

Abstract

Abstract The study aims to investigate the role of microRNA‐149‐3p (miR‐149‐3p) in regulating osteogenic differentiation of human adipose‐derived stem cells (hADSCs) by targeting v‐akt murine thymoma viral oncogene homolog 1 (AKT1). Bioinformatics websites and a dual luciferase reporter assay were used to predict and verify the targeting relationship between miR‐149‐3p and AKT1. The hADSCs were divided into the blank, negative control (NC), mimic, control siRNA, AKT1 siRNA, and miR‐149‐3p inhibitors + AKT1 siRNA groups and then subjected to Alizarin Red staining, Alkaline phosphatase (ALP) staining, ALP activity detections, MTT assay, and EdU cell proliferation assay. Gene or protein expression was quantified using quantitative real‐time PCR (qRT‐PCR) or Western blotting, respectively. The miR‐149‐3p expression increased gradually and AKT1 expression decreased gradually during osteogenic differentiation of hADSCs. The prediction of bioinformatics websites miRTarBase and TargetScan and the dual luciferase reporter assay indicated that miR‐149‐3p can directly target AKT1. After hADSCs were transfected with miR‐149‐3p mimic, AKT1 expression was significantly downregulated. However, transfection with AKT1 siRNA did not have an impact on miR‐149‐3p in hADSCs. In comparison with the AKT1 siRNA group, the miR‐149‐3p inhibitors + AKT1 siRNA group showed decreased miR‐149‐3p expression but increased AKT1 expression. In addition, AKT1 siRNA enhanced the cell viability and proliferation of hADSCs and increased mineral calcium deposition and ALP activity, resulting in higher expression of osteogenic differentiation‐related genes, which was reversed by miR‐149‐3p inhibition. The miR‐149‐3p can increase the expression of osteogenic differentiation‐related genes by targeting AKT1 and thereby enhance the osteogenic differentiation of hADSCs.

Keywords

• AKT1
• hADSC
• miR‐149‐3p
• osteogenic differentiation